Corporate Social Responsibility (CSR), Sustainability and Cause News & Media



Since 2016, Alkermes Inspiration Grants® has awarded more than $3 million in funding to innovative programs that support the comprehensive needs of those most impacted by serious diseases in our therapeutic areas of focus. Applicants and grant recipients include a broad variety of organizations...
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid dependence.
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that fosters equality and compassion, where we strive to make sure that all voices are respected and valued. Our Diversity, Inclusion & Belonging (DIB...
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.



Subscribe to Alkermes